Dergiler / Göztepe Tıp Dergisi / 2003 / Cilt: 18 - Sayı: 2

Çocukluk döneminde skleroderma

Scleroderma in childhood period

Sayfa
110–112
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The first case is an example of localized scleroderma, the second and third ones are examples of systemic sclerosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Scleroderma is an autoimmune disease that is characterized by excessive collagen collection in various internal organs like skin, lung, heart and gastrointestinal system.
📊
Temel Bulgular & Veri:There are two forms of the disease, that's; the systemic one manifested by multiorgan failure due to fibrosis of the internal body systems, and the localized one presented with only the cutaneous, subcutaneous and muscular tissue involment.
💡
Sonuç & Katkı:The first case is an example of localized scleroderma, the second and third ones are examples of systemic sclerosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Scleroderma is an autoimmune disease that is characterized by excessive collagen collection in various internal organs like skin, lung, heart and gastrointestinal system. There are two forms of the disease, that's; the systemic one manifested by multiorgan failure due to fibrosis of the internal body systems, and the localized one presented with only the cutaneous, subcutaneous and muscular tissue involment. In this report, three children presenting with various clinical manifestations involving both forms of the disease are evaluated according to their laboratuary parameters and prognostic factors through last seven years. Cases are reported as this disease is diagnosed very rarely in the childhood period. The first case is an example of localized scleroderma, the second and third ones are examples of systemic sclerosis.

🔖

Bu Makaleye Atıf Yap

PELİT, M., ERGÜVEN, M., KATIÖZ, A. Y., ÖZÇAY, S. (2022). Çocukluk döneminde skleroderma. Göztepe Tıp Dergisi, Cilt: 18 - Sayı: 2, 110–112. https://ajindex.com/articles/526488

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Coleman WP, Derbes VJ, Jolly HW Jr, et al: Collagen disease in children: A review of 71 cases. JAMA 237:1095-1100, 1977
  2. Denardo BA, Tucker LB, Miller LC, et al: Demography of a regional pediatric rheumatology patient population. J Rheumatol 21:1553-1561,1994
  3. Rodnan GP, Myerowitz RL, Justh GO: Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (Scle-roderma) and Raynaud phenomenon. Medicine 59(6):393-408, 1980
  4. Jawitz JC, Albert MK, Nigra TP, et al: A new Skin Manifestation of progressive systemic sclerosis. J Am Acad Dermatbl 11 (2 pt 1 ):265-268,1984 5. Shanks MJ, Blance CE, Adler DP, et al: Radiographic findings of scleroderma in childhood. Am J roeltgenol 141:657-660, 1983
  5. Clements PJ: Clinical aspects of localized and systemic sclerosis. Curr Opinion Rheumatol 4:843-850, 1992
  6. Cassidy JT, Sullivan DB, Dabich L, et al: Scleroderma in children. Arthrtis Rheum 20(2 Suppl):351-354, 1977
  7. Stupi AM, Steen VD, Owens G'R, etal: Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 29:515-524,1986
  8. Steen VD, Medsger TA Jr, Osial TA Jr, et al: Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76:779-786,1984
  9. Follansbee WP: The'cardiovascular manifestations of systemic sclerosis (scleroderma). Curr Probl Cardiol 11:241-298, 1986
  10. Follansbee WP, Curtiss El, Medsger TA Jr, etal: Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma, N Engl J Med 310:142-148,1984,, 12. Frayha, RA, Shulman LE, Stevens MB: Hematoiogical abnormalities scleroderma: A study of 180 cases, Acta Haematol 64:25-30, 1980
  11. Duffy CM, Laxer RM, Lee P, et al: Raynaud syndrome in childhood. J Pediatr 14:73-78,1989
  12. Freundlich B, Jimenez SA, Steen VD, et al: Treatment of systemic sclerosis with recombinant interferqn-gamma: A phase I/II clinical trial. Arthritis Rheum 35:1134-1142,1992
  13. Hein R, Behr J, Hundgen M, et al: Treatment of Systemic sclerosis with gammainterferon. Br J Dermatol 126:496-501,1992.